Financial toxicity of radiotherapy for multiple brain
metastases: Will it get worse or better?

j 2023

Financial toxicity of radiotherapy for multiple brain metastases: Will it get worse or better?

KAZDA, Tomáš a Kateřina POLÁCHOVÁ

Základní údaje

Originální název

Financial toxicity of radiotherapy for multiple brain metastases: Will it get worse or better?

Autoři

KAZDA, Tomáš (203 Česká republika, domácí) a Kateřina POLÁCHOVÁ (203 Česká republika, domácí)

Vydání

NEURO-ONCOLOGY PRACTICE, UNITED STATES, OXFORD UNIV PRESS, 2023, 2054-2577

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku (nerecenzovaný)

Obor

30224 Radiology, nuclear medicine and medical imaging

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.400

Kód RIV

RIV/00216224:14110/23:00134713

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1093/nop/npad018

UT WoS

000981641300001

Klíčová slova anglicky

multiple brain metastases; radiotherapy; financial toxicity

Štítky

rivok

Příznaky

Mezinárodní význam

Změněno: 10. 4. 2024 07:58, Mgr. Tereza Miškechová

Anotace

V originále

For many decades, radiotherapy (RT) has been the primary treatment for patients with limited as well as extended brain metastases. Whole brain radiotherapy (WBRT) was practically the only method often used even in the case of a single brain metastasis (BM), depending on the availability of special RT systems such as the gamma knife. Also nowadays, the availability of modern RT methods is often a decisive factor. In recent years, however, we have witnessed almost revolutionary changes with many new studies in patients with BM defining quality of life and neurocognitive function as important outcomes.1 For many decades we have rather witnessed a lack of interest in multiple BM patients who dogmatically had a very poor prognosis and no treatment method had even the theoretical potential to be superior to WBRT. Thus, it is not surprising that there was not much interest in these studies. The greater the ignorance, the greater the dogmatism (Sir William Osler, 1849–1919).

Návaznosti

NV18-03-00469, projekt VaV

Název: Reakce neuronální populace hipokampu na stereotaktickou radioterapii extratemporálních mozkových metastáz: vliv na neurokognitivní funkce a zachování kvality života

Investor: Ministerstvo zdravotnictví ČR, Reakce neuronální populace hipokampu na stereotaktickou radioterapii extratemporálních mozkových metastáz: vliv na neurokognitivní funkce a zachování kvality života

Citovat

KAZDA, Tomáš a Kateřina POLÁCHOVÁ. Financial toxicity of radiotherapy for multiple brain metastases: Will it get worse or better? NEURO-ONCOLOGY PRACTICE. UNITED STATES: OXFORD UNIV PRESS, 2023, roč. 10, č. 4, s. 318-319. ISSN 2054-2577. Dostupné z: https://dx.doi.org/10.1093/nop/npad018.

@article{2383337,
   author = {Kazda, Tomáš and Poláchová, Kateřina},
   article_location = {UNITED STATES},
   article_number = {4},
   doi = {http://dx.doi.org/10.1093/nop/npad018},
   keywords = {multiple brain metastases; radiotherapy; financial toxicity},
   language = {eng},
   issn = {2054-2577},
   journal = {NEURO-ONCOLOGY PRACTICE},
   note = {Editorial},
   title = {Financial toxicity of radiotherapy for multiple brain metastases: Will it get worse or better?},
   url = {https://academic.oup.com/nop/article/10/4/318/7150653?login=true},
   volume = {10},
   year = {2023}
}

TY  - JFULL
ID  - 2383337
AU  - Kazda, Tomáš - Poláchová, Kateřina
PY  - 2023
TI  - Financial toxicity of radiotherapy for multiple brain metastases: Will it get worse or better?
JF  - NEURO-ONCOLOGY PRACTICE
VL  - 10
IS  - 4
SP  - 318-319
EP  - 318-319
PB  - OXFORD UNIV PRESS
SN  - 20542577
N1  - Editorial
KW  - multiple brain metastases
KW  - radiotherapy
KW  - financial toxicity
UR  - https://academic.oup.com/nop/article/10/4/318/7150653?login=true
N2  - For many decades, radiotherapy (RT) has been the primary treatment for patients with limited as well as extended brain metastases. Whole brain radiotherapy (WBRT) was practically the only method often used even in the case of a single brain metastasis (BM), depending on the availability of special RT systems such as the gamma knife. Also nowadays, the availability of modern RT methods is often a decisive factor. In recent years, however, we have witnessed almost revolutionary changes with many new studies in patients with BM defining quality of life and neurocognitive function as important outcomes.1 For many decades we have rather witnessed a lack of interest in multiple BM patients who dogmatically had a very poor prognosis and no treatment method had even the theoretical potential to be superior to WBRT. Thus, it is not surprising that there was not much interest in these studies. The greater the ignorance, the greater the dogmatism (Sir William Osler, 1849–1919).
ER  -

KAZDA, Tomáš a Kateřina POLÁCHOVÁ. Financial toxicity of radiotherapy for multiple brain metastases: Will it get worse or better? \textit{NEURO-ONCOLOGY PRACTICE}. UNITED STATES: OXFORD UNIV PRESS, 2023, roč.~10, č.~4, s.~318-319. ISSN~2054-2577. Dostupné z: https://dx.doi.org/10.1093/nop/npad018.

Podrobný výpis o publikaci